CORDIS
EU research results

CORDIS

English EN
Organoids for Virus Research - An innovative training-ETN programme

Organoids for Virus Research - An innovative training-ETN programme

Objective

OrganoVIR (Organoids for Virus Research) will train young researchers (ESRs) in the field of organoids and virology. Human viral infection studies lack suitable experimental models as animal models or conventional 2-dimensional (2D) cell cultures do not translate to human infection. OrganoVIR makes use of the breakthrough in the culturing of primary human cells into 3D cultures (organoids). Within this ETN programme, organoids will be used for the first time to study human viral infections in their natural environment.
OrganoVIR includes leading partners in virology and organoid technology covering 7 academic institutes, 3 life science companies, 1 organoid technology private company, 2 non-profit organisations, a national public health institute and a business school originating from 8 countries.
The aim is to introduce and establish human organoids as superior models for viral pathogenesis studies and antiviral testing, thus replacing animal models and reducing animal use. OrganoVIR provides a full package ETN programme for ESRs to learn the science of innovative 3D culture systems for virus research as well as financial, commercial, ethical, communicative, policy and dissemination aspects for optimal valorization. The projects are intensified by significant secondments at commercial, governmental and non-profit partner institutes.
OrganoVIR provides:
- High-ranked scientific and technical training in an interdisciplinary, intersectoral and international top research project
- Training in transferrable managerial skills, including a pre-MBA
- Implementation of innovative organoid technology for viral pathogenesis studies and antiviral development
- Innovation in organoid technology by co-culture design and high throughput screening.
OrganoVIR combines frontier research with an innovative training programme in a complementary network, certifying high impact scientists.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

Academisch Medisch Centrum bij de Universiteit van Amsterdam

Address

Meibergdreef 9
1105az Amsterdam

Netherlands

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 531 239,76

Participants (9)

Sort alphabetically

Sort by EU Contribution

Expand all

KATHOLIEKE UNIVERSITEIT LEUVEN

Belgium

EU Contribution

€ 768 960

UNIWERSYTET JAGIELLONSKI

Poland

EU Contribution

€ 454 957,20

DANMARKS TEKNISKE UNIVERSITET

Denmark

EU Contribution

€ 297 522

STEMCELL TECHNOLOGIES UK LTD

United Kingdom

EU Contribution

€ 303 172,56

UNIVERSITEIT UTRECHT

Netherlands

EU Contribution

€ 265 619,88

CHARLES RIVER NEDERLAND BV

Netherlands

EU Contribution

€ 265 619,88

UNIVERSITE DE GENEVE

Switzerland

EU Contribution

€ 281 276,64

UNIVERSITEIT VAN AMSTERDAM

Netherlands

EU Contribution

€ 265 619,88

UNIVERSITE CLERMONT AUVERGNE

France

EU Contribution

€ 549 604,08

Partners (5)

Sort alphabetically

Expand all

Organome LLC

STICHTING PROEFDIERVRIJ* DUTCH SOCIETY FOR THE REPLACEMENT OF ANIMAL TESTING

RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU

EPITHELIX SARL

KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAW

Project information

Grant agreement ID: 812673

Status

Ongoing project

  • Start date

    1 January 2019

  • End date

    31 December 2022

Funded under:

H2020-EU.1.3.1.

  • Overall budget:

    € 3 983 591,88

  • EU contribution

    € 3 983 591,88

Coordinated by:

Academisch Medisch Centrum bij de Universiteit van Amsterdam

Netherlands